Results 251 to 260 of about 41,516 (300)

Seasonal malaria chemoprevention and mutations in <i>Pfdhfr</i> and <i>Pfdhps</i> genes in children in the health district of Nanoro, Burkina Faso. [PDF]

Malariaworld J
Millogo KS, Zabré A, Sondo P, Kaboré B, Kouevi AFC, Compaoré EW, Bayala IMC, Ismaïla B, Hien SF, Rouamba T, Kazienga A, Derra K, Rouamba E, Tahita MC, Ouédraogo F, Ilboudo H, Bamba S, Tinto H.   +17 more
europepmc   +1 more source

Whole genome analysis of Plasmodium malariae identifies reduced susceptibility to pyrimethamine, validated using ortholog replacement in P. knowlesi

Ibrahim A, Mohring F, Manko E, Schalkwyk Dv, Phelan J, Nolder D, Borrmann S, Adegnika A, Santi SD, Alam MS, Mondal D, Nosten F, Sutherland C, Moon R, Clark T, Campino S.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The multifaceted antineoplastic role of pyrimethamine against human malignancies

IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology, 2021
Cancer accounted for nearly 10 million deaths in 2020 and is the second leading cause of death worldwide. The chemotherapeutic agents that are in clinical practice possess a broad range of severe adverse effects towards vital organs which emphasizes the ...
Shanaya Ramchandani, C. D. Mohan, Jenaifer Rustom Mistry, Q. Su, I. Naz, K. Rangappa, K. Ahn   +6 more
semanticscholar   +1 more source

Chemoprevention by Pyrimethamine

Immunopharmacology and Immunotoxicology, 2005
The goal of the current research was to investigate the chemopreventive potency of an antimalaria drug, pyrimethamine, in in vitro conditions. The fibrosarcoma (WEHI-164) cell line was used for evaluating cytotoxicity, matrix metalloproteinase 2 (MMP-2) activity, and apoptosis. Pyrimethamine and methotrexate were used at concentrations of 0-8 microg/ml
Mohammad Reza Khorramizadeh, Farshid Saadat, Abbas Mirshafiey   +2 more
openaire   +3 more sources

SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE AND SULFADOXINE/PYRIMETHAMINE IN KISUMU, KENYA

The Lancet, 1982
Field studies were conducted in Kisumu, Kenya, to assess the susceptibility of local strains of Plasmodium falciparum to pyrimethamine alone (by a standard 7-day in-vivo test and a 48 h in-vitro field test) and to sulfadoxine-pyrimethamine (by a 7-day in-vivo test).
Shemey Chemangey-Masaba, Harrison C. Spencer, Phuc Nguyen-Dinh, FrederickC. Churchill   +3 more
openaire   +3 more sources

Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979
The effect of pyrimethamine and the combination of pyrimethamine-sulfadoxine (Fansidar) upon the termination of the acute attack of vivax malaria was studied in Thailand. Pyrimethamine was found to be ineffective, providing clearance of parasitaemia in only two of six patients by the end of seven days following treatment.
C. Teerakiartkamjorn, S. Noeypatimanondh, R.G. Andre, E. B. Doberstyn, P. Phintuyothin   +4 more
openaire   +3 more sources